Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. TABLE 1C from Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Antitumor Activity Against Prostaglandin-Expressing Tumors
  1. Home
  2. Publications
  3. TABLE 1C from Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Antitumor Activity Against Prostaglandin-Expressing Tumors

TABLE 1C from Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Antitumor Activity Against Prostaglandin-Expressing Tumors

Authors:
  • BFBrian J. Francica
    Brian J. Francica
  • AHAnja Holtz
    Anja Holtz
  • JLJustine Lopez
    Justine Lopez
  • DFDavid Freund
    David Freund
  • ACAustin Chen
    Austin Chen
  • DWDingzhi Wang
    Dingzhi Wang
  • DPDavid Powell
    David Powell
  • FKFranciele Kipper
    Franciele Kipper
  • DPDipak Panigrahy
    Dipak Panigrahy
  • RDRaymond N. Dubois
    Raymond N. Dubois
  • CWChan C. Whiting
    Chan C. Whiting
  • PPPeppi Prasit
    Peppi Prasit

Open Access
Publisher website
Google Scholar
  • 8 August 2023
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/2767-9764.23905675.v1
Abstract
Antibodies used for IHC of CT26 tumors
Keywords
  • DUAL BLOCKADE
  • OPTIMAL IMMUNE
  • IMMUNE ACTIVATION
  • ANTITUMOR ACTIVITY
  • TUMORS ANTIBODIES
  • PROSTAGLANDIN-EXPRESSING TUMORS
  • TABLE
  • SIGNALING
  • TUMORS
  • DUAL
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.